Cited 0 time in
Primary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이우진 | - |
| dc.contributor.author | 윤숙정 | - |
| dc.contributor.author | 정준민 | - |
| dc.contributor.author | 고주연 | - |
| dc.contributor.author | 김광호 | - |
| dc.contributor.author | 김동현 | - |
| dc.contributor.author | 김명화 | - |
| dc.contributor.author | 김유찬 | - |
| dc.contributor.author | 김정은 | - |
| dc.contributor.author | 나찬호 | - |
| dc.contributor.author | 문제호 | - |
| dc.contributor.author | 박종빈 | - |
| dc.contributor.author | 박지혜 | - |
| dc.contributor.author | 박혜진 | - |
| dc.contributor.author | 신동훈 | - |
| dc.contributor.author | 신정현 | - |
| dc.contributor.author | 오상호 | - |
| dc.contributor.author | 윤석권 | - |
| dc.contributor.author | 이동윤 | - |
| dc.contributor.author | 이석종 | - |
| dc.contributor.author | 이승호 | - |
| dc.contributor.author | 이영복 | - |
| dc.contributor.author | 조소연 | - |
| dc.contributor.author | 최수연 | - |
| dc.contributor.author | 최재은 | - |
| dc.contributor.author | 이미우 | - |
| dc.date.accessioned | 2025-04-13T16:30:19Z | - |
| dc.date.available | 2025-04-13T16:30:19Z | - |
| dc.date.issued | 2025-04 | - |
| dc.identifier.issn | 1013-9087 | - |
| dc.identifier.issn | 2005-3894 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/58156 | - |
| dc.description.abstract | Background: Primary cutaneous CD30+ lymphoproliferative disorders (pcCD30-LPDs) are a diseases with various clinical and prognostic characteristics. Objective: Increasing our knowledge of the clinical characteristics of pcCD30-LPDs and iden- tifying potential prognostic variables in an Asian population. Methods: Clinicopathological features and survival data of pcCD30-LPD cases obtained from 22 hospitals in South Korea were examined. Results: A total of 413 cases of pcCD30-LPDs (lymphomatoid papulosis [LYP], n=237; primary cutaneous anaplastic large cell lymphoma [C-ALCL], n=176) were included. Ninety percent of LYP patients and roughly 50% of C-ALCL patients presented with multiple skin lesions. Both LYP and C-ALCL affected the lower limbs most frequently. Multiplicity and advanced T stage of LYP lesions were associated with a chronic course longer than 6 months. Clinical morphology with patch lesions and elevated serum lactate dehydrogenase were significantly associated with LPDs during follow-up in LYP patients. Extracutaneous involvement of C-ALCL occurred in 13.2% of patients. Lesions larger than 5 cm and increased serum lactate dehydrogenase were associated with a poor prognosis in C-ALCL. The survival of patients with C-ALCL was unaffected by the anatomical locations of skin lesions or other pathological factors. Conclusion: The multiplicity or size of skin lesions was associated with a chronic course of LYP and survival among patients with C-ALCL. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한피부과학회 | - |
| dc.title | Primary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5021/ad.24.120 | - |
| dc.identifier.scopusid | 2-s2.0-105002788251 | - |
| dc.identifier.wosid | 001455256600003 | - |
| dc.identifier.bibliographicCitation | Annals of Dermatology, v.37, no.2, pp 75 - 85 | - |
| dc.citation.title | Annals of Dermatology | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 75 | - |
| dc.citation.endPage | 85 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART003185345 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Dermatology | - |
| dc.relation.journalWebOfScienceCategory | Dermatology | - |
| dc.subject.keywordPlus | LARGE-CELL LYMPHOMA | - |
| dc.subject.keywordPlus | TNM CLASSIFICATION-SYSTEM | - |
| dc.subject.keywordPlus | LYMPHOPROLIFERATIVE DISORDERS | - |
| dc.subject.keywordPlus | MYCOSIS-FUNGOIDES | - |
| dc.subject.keywordPlus | EUROPEAN-ORGANIZATION | - |
| dc.subject.keywordPlus | PAPULOSIS | - |
| dc.subject.keywordPlus | SURVIVAL | - |
| dc.subject.keywordPlus | ASSOCIATION | - |
| dc.subject.keywordPlus | DIAGNOSIS | - |
| dc.subject.keywordPlus | FEATURES | - |
| dc.subject.keywordAuthor | Anaplastic large cell lymphoma | - |
| dc.subject.keywordAuthor | Clinical course | - |
| dc.subject.keywordAuthor | Cutaneous T-cell lymphoma | - |
| dc.subject.keywordAuthor | Lymphomatoid papulosis | - |
| dc.subject.keywordAuthor | Prognostic factors | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
